Physician profile
Gregory C Thom
NPI 1689802977
$1,893.61
in general payments reported to CMS, 2019-2025
7 companies · $393 in 2025
The $393 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $167 · 2021: $475 · 2022: $136 · 2023: $387 · 2024: $44.25 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $748.64 | 2019-2025 | Zenith, Zenith Spiral-Z |
| W. L. Gore & Associates, INC. | $434.19 | 2019-2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Surmodics, INC. | $222.80 | 2023 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Boston Scientific Corporation | $193.79 | 2025 | Enroute Transcarotid Neuroprotection System |
| Medtronic, INC. | $107.68 | 2021-2023 | Endurant Iis |
| Medtronic Vascular, INC. | $99.61 | 2019 | |
| Shockwave Medical, INC | $86.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Thom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.